Related references
Note: Only part of the references are listed.Japanese Encephalitis Vaccine (Inactivated, Adsorbed) [IXIARO (R)]
Sean T. Duggan et al.
DRUGS (2009)
A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: Immunogenicity and anamnestic responses
Young Mo Sohn et al.
VACCINE (2008)
Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: A case-control study in Nepalese children 5 years after immunization
J. B. Tandan et al.
VACCINE (2007)
Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004
J Hombach et al.
VACCINE (2005)
Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax™-JE experimental vaccine
DWC Beasley et al.
VACCINE (2004)
Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): Phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen
TP Monath et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Clinical proof of principle for ChimeriVax™:: recombinant live, attenuated vaccines against flavivirus infections
TP Monath et al.
VACCINE (2002)
Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains
I Kurane et al.
VACCINE (2000)
Japanese encephalitis
T Solomon et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2000)
Share Paper
